Manufacturers Life Insurance Company, The Monte Rosa Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 117,877 shares of GLUE stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117,877
Previous 102,709
14.77%
Holding current value
$1 Million
Previous $384,000
62.5%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding GLUE
# of Institutions
83Shares Held
43.9MCall Options Held
141KPut Options Held
31.2K-
Nea Management Company, LLC Timonium, MD7.69MShares$65.3 Million3.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$56 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.79MShares$49.2 Million0.46% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$41.7 Million0.28% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.66MShares$22.6 Million0.55% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $397M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...